Latest Press Releases
View all
TimeHeadline
26m agoSunrun Prices $584 million Securitization of Residential Solar and Storage Assets
27m agoMadison Air Schedules First Quarter 2026 Earnings Conference Call and Webcast
51m agoUltra Clean Announces Retirement of the Chief Financial Officer Sheri Savage
51m agoGridAI Technologies Corp. Announces Receipt of NASDAQ Notice Regarding Late Form 10-K Filing
51m agoRush Enterprises, Inc. Reports First Quarter 2026 Results, Announces $0.19 Per Share Dividend
Eterna Therapeutics Inc logo

Eterna Therapeutics Inc

About

Eterna Therapeutics Inc (NASDAQ:ERNA) — investor relations, events, news, and company updates on 6ix.

Latest News

Feb 20 2026
Ernexa Therapeutics to Participate in Virtual Investor Closing Bell Series
Feb 6 2026
Ernexa Therapeutics Announces Pricing of $10.5 Million Public Offering
Feb 3 2026
Ernexa Therapeutics Participates in Virtual Investor “What This Means” Segment Highlighting Recent Successful Pre-IND Meeting with U.S. FDA
Jan 27 2026
Ernexa Therapeutics Selected as One of Only Ten Global Companies for Prestigious JETRO Japan Entry Acceleration Program
Jan 6 2026
Ernexa Therapeutics Announces Successful Pre-IND FDA Meeting and Continues Progress Toward First-in-Human Trial in Ovarian Cancer

Financials

Revenue
$1 K
Market Cap
$6.11 M
EPS
-2.24

Community Chat

Ask AI

6ix6ix